ArticleTranslational cancer research2026

Long-term safety and efficacy of BCMA-directed CAR T-cell therapies in multiple myeloma: comparative insights from Cilta-cel, Ide-cel, Anito-cel, and FCARH143.

Bryanna Reinhardt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.